• FDA Slashes Fees for Priority Review Voucher

    The US Food and Drug Administration (FDA) has announced the release of fee rates for using tropical disease priority review vouchers for the upcoming year, slashing fees more than 32% from 2012. The tropical disease voucher system was established under the FDA Amendment Act of 2007 (FDAAA) , which authorized a novel program. Under it, companies that receive approval for a tropical disease treatment are eligible to receive a transferrable voucher that allows the bear...